GSK Investigational Site

Giessen, Hesse 35392

0 studies enrolling now · 9 studies all time

What they study most

Acute Coronary Syndrome, Epilepsy, Epilepsy, Partial, Hypertension, Pulmonary, Prostatic Hyperplasia, Purpura, Thrombocytopaenic, Idiopathic, Sepsis, Urinary Tract Infections

Studies at this site

• A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI) — Completed
• Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529 — Completed
• Efficacy and Safety of Ambrisentan in Children 8-18yrs — Stopped early
• A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) — Completed
• GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults — Completed
• A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60) — Completed
• RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag — Completed
• Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment — Completed
• Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures — Completed